MCC MiLo vs TherapySelector

Deze app is een cadeau aan de regio Midden-Limburg oost (miLo), aangeboden door de Uitvlucht-organisatie tijdens een tweejaarlijkse conferentie in 2015. De "Uitvlucht"stelt zich als doel een bijdrage te leveren aan goede communicatie en samenwerking binnen de regionale gezondheidszorg en is er van overtuigd dat professionals elkaar daarvoor moeten kennen en elkaar moeten kunnen bereiken. Deze app ondersteunt dat op een directe en simpele manier. De miLo-app bevat een smoelenboek (wie is wie) met daarin de contactgegevens van de huisartsen, medisch specialisten, apothekers en specialisten ouderengeneeskunde in de regio Midden-Limburg-oost. Tevens zijn alle werkafspraken (Regionale Transmurale Afspraken) van in de app te vinden, welke zijn opgesteld door huisartsen en medisch specialisten tezamen. Er kunnen werkafspraken gezocht worden op categorie, op alfabet, en door middel van een algemene zoekfunctie. Ook bevat de app de laatste nieuwsbrieven . Voor het smoelenboek hebben gebruikers een inlogcode en verbinding met internet nodig. De werkafspraken en nieuwsbrieven zijn voor iedereen zichtbaar en offline beschikbaar. De inhoud van de app wordt regelmatig geactualiseerd. Disclaimer: De medische informatie in deze app is samengesteld in samenwerking tussen huisartsen en medisch specialisten in de regio Midden Limburg Oost met als doel de samenwerking te optimaliseren. De informatie is niet bedoeld als een richtlijn of hulp voor patiënten. Neem bij klachten contact op met uw huisarts!

TherapySelector supports you as a physician to easily and quickly choose a data-based, person-centered treatment for hypertension and hepatitis C for and with your patient during consultation hours. The app shows in a single glance information about the effectiveness of medication based on the disease remission (systolic blood pressure lower than 140 mmHg for hypertension and viral clearance in hepatitis C), the likelihood of adverse events, cost and patient group size. This overview allows you to easily and quickly decide on the best person-centered treatment method for your patient, based on study data. How does TherapySelector work? First you enter the requested characteristics of your patient by answering 4 simple questions about etiology, disease stage, previous treatments and comorbidities. Based on this, a profile of the patient is determined. The app then shows an overview of all registered treatments for that specific patient profile, based on frequently updated study results. For each therapy you find information about effectiveness, possible adverse events and costs. TherapySelector currently provides the following features: • Determination of patient profiles based on four simple questions about the patient. • Probability of "success" of all registered medication (combinations) for hypertension and hepatitis C, together with the probability of adverse events associated with the patient profile, based on individual patient data from key clinical scientific studies. • For hypertension: overview of therapy options with Thiazide diuretics (THZ), Calcium Channel Blockers (CCA), ACE inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB). Information on monotherapy with dose increase (Titrate), and results of stepwise addition of medication (Titrate & Add). • Detail information, including information about dosage (of the therapy regime) and the cost of a specific treatment. • Availability in both English and Dutch. TherapySelector is intended to provide physicians and patients person-centered information to support them in choosing the most appropriate treatment. In doing so, the app complements guidelines that are based on the ‘average’ patient. The TherapySelector app can be used without creating an account. Developed with (academic) medical centers and research institutes TherapySelector is developed by TherapySelector in collaboration with physicians and scientists associated with universities and leading academic medical centers such as the Erasmus MC, LUMC and MUMC+. The data in the app has been authorized by specialists from Dutch scientific associations. The results are calculated using anonymous patient data from scientific studies of published randomized controlled trials, other phase 2 & 3 studies and prospective real-life studies around the world (high quality research). Research groups and sponsors make their data available for this purpose. About TherapySelector TherapySelector B.V. is a social enterprise. Our mission is to improve health care globally by enriching it with person-centered treatment information based on the most recent data from scientific studies. It is not our goal to make profit. With the TherapySelector app, we facilitate doctors with person-centered care to achieve health gains for their patients. Additionally, we want to aid in controlling the rising costs of healthcare for the public, e.g. by preventing over- and under-treatment. Follow us on LinkedIn (https://www.linkedin.com/company/therapyselector) or visit www.therapyselector.com.